Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
39S ribosomal protein L32, mitochondrial (MRPL32) is a nuclear-encoded protein that integrates into the mitochondrial large ribosomal subunit and is essential for mitochondrial protein synthesis[3][5][7][9]. MRPL32 contains a specialized domain that coordinates zinc ions via a conserved cysteine motif (CxxC-X9-CxxC), contributing both to folding and function[2][8]. Its proper processing and maturation are regulated by the m-AAA protease, which ensures that MRPL32 integrates correctly into the ribosome, influencing biogenesis and assembly of mitochondrial respiratory complexes[2][1]. MRPL32 is not an enzyme or a classical therapeutic target such as a receptor, transporter, or ion channel, and there are no drugs currently known to interact directly with it. Defects or dysregulation in MRPL32 may contribute to impaired mitochondrial protein synthesis, with potential secondary relevance in mitochondrial disorders[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 39S ribosomal protein L32, mitochondrial (MRPL32).